Advertisement
UK markets close in 3 hours 45 minutes
  • FTSE 100

    8,086.33
    +41.52 (+0.52%)
     
  • FTSE 250

    19,802.71
    +2.99 (+0.02%)
     
  • AIM

    754.77
    -0.10 (-0.01%)
     
  • GBP/EUR

    1.1637
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2435
    -0.0017 (-0.14%)
     
  • Bitcoin GBP

    53,520.41
    +501.73 (+0.95%)
     
  • CMC Crypto 200

    1,438.08
    +13.98 (+0.98%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.89
    -0.47 (-0.56%)
     
  • GOLD FUTURES

    2,328.30
    -13.80 (-0.59%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,187.70
    +50.05 (+0.28%)
     
  • CAC 40

    8,136.42
    +30.64 (+0.38%)
     

NVS and NVO: Which Has Higher Upside Potential?

NVS and NVO: Which Has Higher Upside Potential?

Novartis’s (NVS) EV (enterprise value) is $206.9 billion and its EV-to-revenue ratio is 4.1. The stock is trading at a forward PE (price-to-earnings) ratio of 13.3, and its PEG (price-to-earnings-to-growth) ratio is 2.2. At present, Novartis’ price-to-sales ratio is 3.6, and its price-to-book ratio is 2.4.